General Information |
| Clinical trials phase |
Phases 1/2 |
| Start date (estimated) |
2023-10-18 |
| Clinical feature |
| Label |
Macular pigment epithelial rip |
| Link |
http://snomed.info/id/247159009 |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCT2073230077 |
| Other study identifiers |
| Name |
jRCT2073230077 |
| Description |
Japan Registry of Clinical Trials (jRCT) |
|
| Source weblink |
https://jrct.niph.go.jp/latest-detail/jRCT2073230077 |
| Public contact |
| Email |
cc@sumitomo-pharma.co.jp |
| Public email |
cc@sumitomo-pharma.co.jp |
| First name |
Product information center |
| Last name |
Sumitomo Pharma Co., Ltd. |
| Phone |
+81-120-034-389 |
| Street |
6-8, Doshomachi 2-chome |
| City |
Osaka |
| Country |
|
| Address freetext |
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045, Japan 541-0045 Osaka Japan |
|
| Sponsors |
Sumitomo Pharma Co., Ltd.
|
Cells |
| Which differentiated cell type is used |
| Label |
retinal pigment epithelial cell |
| Link |
http://purl.obolibrary.org/obo/CL_0002586 |
| Description |
An epithelial cell of the retinal pigmented epithelium. |
|
Recruitment |
| Recruitment Status |
Recruiting |
| Estimated number of participants |
21 |
